Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation

Antiviral therapy for recurrent hepatitis C in liver transplant recipients has been associated with low efficacy, poor tolerability, and drug-drug interactions. Recent approval of various hepatitis C direct-acting antivirals has resulted in improvement of these parameters. We evaluated the efficacy...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Transplant Direct
Egile Nagusiak: Khemichian, Saro, Lee, Brian, Kahn, Jeffrey, Noureddin, Mazen, Kim, Brian, Harper, Tammy, Esmailian, Yvonne, Fong, Tse-Ling
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2015
Gaiak:
Original Clinical Science
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946469/
https://ncbi.nlm.nih.gov/pubmed/27500223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000531
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak